Ask AI
H.R. 2433

To amend the Federal Food, Drug, and Cosmetic Act with respect to enhancing combination products review.

This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration to describe the responsibilities of each agency center charged with reviewing drugs, medical devices, or biological products when reviewing a product that is a combination of drug, medical device, or biological product.

Referred to the Subcommittee on Health.

Rep. Bilirakis, Gus M. [R-FL-12](R-FL)Sponsor
1committees4actions1related bills4subjects
  1. Committee

    Referred to the Subcommittee on Health.

    Health Subcommittee
  2. IntroReferralH11100

    Referred to the House Committee on Energy and Commerce.

    Energy and Commerce Committee
  3. IntroReferralIntro-H

    Introduced in House

  4. IntroReferral1000

    Introduced in House

To amend the Federal Food, Drug, and Cosmetic Act with respect to enhancing combination pr… — Informed